Skip to main content
. 2017 Oct 13;8(61):103393–103409. doi: 10.18632/oncotarget.21900

Figure 5. Agonist and antagonist assays of DH on HEK293/Gα15/ETB cell line.

Figure 5

(A) Agonist assay of the HEK293/Gα15/ETB cell line. Dose-response curve for ET-1, with EC50 value of 11.6 nM. (B) Antagonist assay of the HEK293/Gα15/ETB cell line. Dose-response curve for bosentan, with IC50 value of 616.5 nM. (C) Antagonist assay of DH on HEK293/Gα15/ETB cell line. Dose-response curve for DH, with IC50 value of 25.67 μL/mL.